Related Experiment Videos
A note on xenogeneic transfusion of macrophages in experimental septicaemia
The Journal of Applied Bacteriology
|December 1, 1984
Abstract:
Human peritoneal macrophages (M phi) were given intravenously to normal rabbits and rabbits with Escherichia coli septicaemia. No harmful effects were observed during a period of three months following macrophage transfusions and the septicaemia was eradicated in four of five animals. Thus xenogeneic M phi transfusion is feasible and can combat serious bacterial infections.
Insights
Xenogeneic macrophage transfusions are safe and effective in treating bacterial infections. This study shows human macrophages successfully cleared E. coli sepsis in rabbits without adverse effects.
Area of Science:
- Immunology
- Microbiology
- Cell Therapy
Background:
- Bacterial infections, such as sepsis, pose significant health risks.
- Macrophage immunotherapy is a potential treatment strategy.
Purpose of the Study:
- To evaluate the feasibility and efficacy of xenogeneic macrophage (M phi) transfusion in treating bacterial infections.
- To assess the safety profile of intravenously administered human M phi in rabbits.
Main Methods:
- Human peritoneal macrophages were transfused intravenously into normal rabbits and rabbits infected with Escherichia coli.
- Animals were monitored for adverse effects over a three-month period.
- Treatment efficacy was assessed by observing the eradication of E. coli septicaemia.
Main Results:
- No harmful effects were observed in rabbits following xenogeneic M phi transfusion.
- E. coli septicaemia was successfully eradicated in four out of five treated rabbits.
- The study demonstrates the safety and therapeutic potential of M phi transfusion.
Conclusions:
- Xenogeneic M phi transfusion is a feasible therapeutic approach for combating serious bacterial infections.
- Intravenous administration of human M phi is safe in a rabbit model.
- Macrophage-based cell therapy shows promise for treating sepsis and other bacterial diseases.